Ischemia modified albumin (IMA), as measured using the albumin cobalt binding test, is
currently the most promising biomarker for early detection of ischemia before the onset of …

Background: Ischemia-modified albumin has been proposed as a useful rule-out marker for
the diagnosis of acute coronary syndrome in the emergency department. Objective: To …

Background: Alopecia areata (AA) is an autoimmune-mediated hair follicle disorder. In the
literature, there is no study evaluating metabolic syndrome and levels of ischemia-modified …

Ischemia modified albumin is a novel marker of ischemia generated due to hypooxygenation
and increased hydroxyl free radicals in low pH. The molecule has been licenced for clinical …

Human serum albumin (HSA) serves not only as a physiological oncotic pressure regulator
and a ligand carrier but also as a biomarker for pathologies ranging from ischemia to …

Background/aims: A meta-analysis of maternal serum ischemia-modified albumin (IMA) and
fetal cord-blood IMA concentrations in normal pregnancy (NP) compared to non-pregnant …

Objectives The aim of this study was to evaluate the efficiency of ischemia-modified albumin
(IMA) for predicting major adverse cardiovascular events (MACE) in continuous ambulatory …

Purpose Oxidative stress has been implicated in several disorders, including acute
pancreatitis (AP). Ischemia-modified albumin (IMA), which reflects the ability to bind cobalt …

Background Free radical-mediated oxidative stress (OS) has been implicated in the
pathogenesis of thyroid disorders. The ischemia-modified albumin (IMA) has been proposed …

Scientific knowledge should be based on evidence. However, some scientific studies can be
carried out without sufficient evidence. And these studies may mislead subsequent studies …